01 5Xospata
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 203
2019 Revenue in Millions : 107
Growth (%) : 89
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 269
2020 Revenue in Millions : 201
Growth (%) : 44
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 358
2021 Revenue in Millions : 287
Growth (%) : 25
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 348
2022 Revenue in Millions : 358
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 109
2018 Revenue in Millions : 6
Growth (%) : 1,850
